NCT05575141

Brief Summary

In the treatment of ventral incisional hernias, a mesh repair in the retromuscular plane is considered as the gold standard. To allow for adequate medialization of the fascial borders and a complete closure of the defect in case of large incisional hernias, component separation techniques are increasingly being used. When compared to anterior component separation, posterior component separation by transversus abdominis release (TAR) seems to decrease postoperative wound problems. While laparoscopic techniques pose significant difficulties to perform TAR minimally invasively (mainly due to ergonomic and technical reasons), these limitations seem to be overcome by robotic platforms. Initial retrospective patient series report on significantly shorter postoperative hospital stay and fewer complications after robotic transversus abdominis release (rTAR), when compared to open transversus abdominis release (oTAR). High-quality prospective evidence on rTAR is currently lacking.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
81mo left

Started Jul 2025

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress11%
Jul 2025Jan 2033

First Submitted

Initial submission to the registry

April 2, 2022

Completed
6 months until next milestone

First Posted

Study publicly available on registry

October 12, 2022

Completed
2.7 years until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2028

Expected
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2033

Last Updated

April 11, 2025

Status Verified

April 1, 2025

Enrollment Period

2.5 years

First QC Date

April 2, 2022

Last Update Submit

April 10, 2025

Conditions

Keywords

Abdominal Wall Herniarobotic TAR (rTAR)open TAR (oTAR)transversus abdominis release (TAR)

Outcome Measures

Primary Outcomes (1)

  • Length of postoperative hospital stay

    Length of postoperative hospital stay

    hours from the end of surgery (last skin suture) until discharge, assessed up to 20 days

Secondary Outcomes (12)

  • Skin-to-skin operative time

    Per-operative (minutes)

  • Conversion rate

    Per-operative

  • Surgical site related complications

    30 days

  • Readmission rate

    30 Days and 3 months postoperative

  • Post-anesthetic discharge scoring system

    From the end of surgery (last skin suture) until discharge, assessed up to 20 days

  • +7 more secondary outcomes

Study Arms (2)

rTAR

ACTIVE COMPARATOR

Patients randomized in the robotic group will undergo the technique for intra-and perioperative management for robotic complex abdominal wall repair cases as used in the center. A robotic surgical platform (da Vinci X or da Vinci Xi Surgical System, Intuitive Surgical, Aubonne, Switzerland) will be used and a retrorectus +/- retromuscular mesh placement performed. Use of component separation or not will be at the discretion of the surgeon. In principle the posterior layer and the anterior fascia will be closed avoiding a bridging technique. Drain management and mesh fixation are left to the surgeon's preference.

Procedure: incisional hernia repair

oTAR

ACTIVE COMPARATOR

Patients randomized in the open group will undergo the technique for intra-and perioperative management for open complex abdominal wall repair cases as used in the center. A retrorectus +/- retromuscular mesh placement performed. Use of component separation or not will be at the discretion of the surgeon. In principle the posterior layer and the anterior fascia will be closed avoiding a bridging technique. Drain management and mesh fixation are left to the surgeon's preference.

Procedure: incisional hernia repair

Interventions

Incisional hernia repair for the treatment of wide ventral incisional hernias.

oTARrTAR

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- All patients requiring treatment of a wide ventral incisional hernia (of more than 8 centimetres in width)

You may not qualify if:

  • Pregnant or suspected pregnancy
  • Not-curatively treated malignancy, with life expectancy less than 24 months
  • Patients unable to give informed consent or complete study specific questionnaires
  • Emergency surgery
  • Primary ventral hernia repair
  • Exclusively lateral hernias not involving the midline
  • Incisional hernia repair after open abdomen or enterocutaneous fistula
  • Active wound infection
  • Previous anterior or posterior component separation
  • Patients with an existing ostomy
  • Patients with a life expectancy of less than 24 months
  • Patients suspected of being unable to comply with the study protocol

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Hernia, Abdominal

Condition Hierarchy (Ancestors)

HerniaPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • Filip Muysoms, MD PhD

    Clinical research center Maria Middelares

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Maaike Vierstraete, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
This is an open-label Randomized Controlled Trial (RCT) where the patient, surgeon, research coordinators and hospital staff will be aware of the treatment arm after randomization. As the open approach is performed using a large midline incision, whereas the robotic approach applies only 6 or 7 small incisions (or less if no posterior component separation is needed), blinding of patients and physicians is difficult. Evaluation of the radiographic imaging of the abdominal wall at 24 months (MRI or CT scan) will be done by radiologists at the local participating center blinded to the randomized treatment arm. This will be a blinded evaluation for the presence or absence of hernia recurrence. Data analysis will be performed in a blinded manner by an independent statistician.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: a multicenter international randomized controlled trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of General Surgery

Study Record Dates

First Submitted

April 2, 2022

First Posted

October 12, 2022

Study Start

July 1, 2025

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

January 1, 2033

Last Updated

April 11, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share